Fenofibrate Capsule
Product Images NDC 60505-3120

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 60505-3120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl130mg30s (Lbl130mg30s)

Fenofibrate Capsules, USP is a medication that comes in a container of 30 capsules, with each capsule containing 130 mg of micronized Fenofibrate, USP. The medication should be stored at controlled room temperature (20°C to 25°C) in a tight container. The manufacturing company is Apotex Inc., located in Toronto, Ontario, Canada, and it is marketed by Apotex Corp., based in Weston, Florida.*

FDA Label Image

Lbl43mg30s (Lbl43mg30s)

This is a description of Fenofibrate capsules, USP which contains 43 mg of micronized Fenofibrate per capsule. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with permitted excursions between 10°C to 30°C (59°F to 86°F) as per USP Controlled Room Temperature. It is advised to dispense the capsules in a tight container. The usual dosage information can be found in the package insert. The product is manufactured by Apotex Corp and is available in a pack of 30 capsules with NDC code 60505-3120-3.*

FDA Label Image

Chemical-structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.